Just received this e-mail question from mb wood:
“Has anyone had any real real results with the novel therapies? Do the new drugs work?”
The answer to this question is an unqualified YES! Novel therapies for multiple myeloma, and other hematological cancers, include any non-traditional chemotherapy drug. Thalidomide, Revlimid, Velcade, and many of the other, newer myeloma drugs being developed now are all considered “novel therapies.” Novel in the sense that, unlike traditional chemotherapy–which kills both cancer and healthy cells–these drugs target the myeloma cells only. For examply, Revlimid restricts blood flow to the myeloma cells without killing bone marrow indiscriminately like a more traditional chemotherapy drug like melphalan or cytoxan. The definition of novel therapy agents is so broad, it makes this an easy question. Almost all myeloma patients respond in a positive way to one or more of these novel therapy agents at sometime during their treatment. And the great news is there are more novel therapy drugs on the way! The not so good news is none of these drugs are cures for the majority of myeloma patients. Sort of a good news/bad news answer.
Feel good and keep smiling! Pat